hCav1.2 recordings on Qube 384 using step, train and CiPA protocols - Sophion

hCav1.2 recordings on Qube 384 using step, train and CiPA protocols


Journal: Sophion application report
View file
Author(s): Melanie Schupp, Kadla R Rosholm


The development of screening assays for the CaV1.2 channel has been challenging due to the tendency of CaV1.2 expressing cell lines to exhibit declining current levels (rundown) during the experiment1,2. Here we report a robust CaV1.2 assay yielding high success rates, low rundown and reliable pharmacology.

 

Pharmacology and current-voltage relationship in accordance with literature values

 

Success rates up to 94%

 

Stable currents with rundown as low as (1.2 ± 0.9)% per minute

 

The CiPA protocol yields stable currents with rundown as low as (1 ± 1)% per minute

Contact

Contact Sophion

Sophion Bioscience A/S
Baltorpvej 154, 2750 Ballerup, Denmark
Telephone: +45 44 60 88 00

You need to fill in all required fields.

When opting-in for our newsletter you will receive 4-6 newsletters per year. You can always opt-out directly from the newsletters. For more information see our privacy policy